A recent study publication by Krohn et al. demonstrated that up to 94.0% of prostate cancer patients with PSMA-PET/CT show intense PSMA-ligand uptake in at least one coeliac ganglia (15). The gene discussed is FOLH1; the disease is prostate carcinoma.